Cite

    Wang, J., Gong, G., Zhou, Y., Lee, W., Buchanan, C., Denny, W., Rewcastle, G., Kendall, J., Dickson, J., Flanagan, J., Shepherd, P., Yang, D., & Wang, M. (2018). high-throughput screening campaigns against a PI3Kα isoform bearing the H1047R mutation identified potential inhibitors with novel scaffolds. Acta pharmacologica Sinica, 39, 1816–1822. http://access.bl.uk/ark:/81055/vdc_100086017757.0x00019b